CClinicalTrials.gg
Status unknownNCT05020223Updated Aug 25, 2021

Comparison of Sucess of Pulpotomy, Direct Pulp Capping and Indirect Pulp Capping Modalities Using MTA in Primary Teeth

An interventional study of Vital pulp therapy in Deep Caries, sponsored by Minia University. Status unknown at 1 site in Egypt. Open to participants aged 3 Years to 10 Years. Per ClinicalTrials.gov, last updated 2021-08-25.

Sponsored by Minia University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2021), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Aug 2020, registered Aug 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
450
Allocation
Randomized
Ages
3 Years to 10 Years
Sex
All
01

Study summary

450 healthy children with primary teeth of deep carious lesions without signs or symptomes of irreverisible pulp damage was selected randompy divoded into 3 groups each of 150 children that inder go vital pulp therapy through pulpotomy,direct pulp capping or indirect pulp capping using MTA as capping material for each modality then followed up for 2 years or more

02

Conditions studied

  • Deep Caries
03

In context

Lead sponsor

Minia University is the lead sponsor of 356 studies on the registry; 115 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Healthy children
  • Aged from 3 to 10 years old
  • Deep cariuos primary tooth

Exclusion criteria

Exclusion Criteria:

  • Primary teeth with any signs or syptoms of irreversible pulpitis
  • Primary teeth of any signs or symptomes of vitality loss
  • Primary teeth near to exfoliation
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
450 participants (estimated)

Study arms

  • Experimental
    MTA pulpotomy

    Usuing MTA as capping material for cervical pulpotomy as a treatment option for deep carious primary teeth with signs and symptoms of reversible pulpitis in presence of pulp exposure

    Other: Vital pulp therapy

  • Experimental
    MTA direct pulp capping

    Using MTA as capping material in case of trearment of deep carious primary teeth with signs and symptoms of reversible pulpitis with presence of pulp exposure

    Other: Vital pulp therapy

  • Experimental
    MTA indirect pulp capping

    Using MTA as indirect capping material for treatment of deep carious primary teeth with signs and symptoms of reversible pulpitis

    Other: Vital pulp therapy

Interventions

  • OtherVital pulp therapy

    Vital pulp therapy different modalities for management of deep carious lesion in primary teeth

06

What researchers measure

Primary outcomes

  1. Tenderness

    Precence or abscence

    Time frame: 2 years

  2. Abcess

    Precence or abscence

    Time frame: 2 years

  3. Fistula

    Precence or abscence

    Time frame: 2 years

  4. lamina dura

    Intact or distorted

    Time frame: 2 years

  5. Periapical radiographic radiolucency

    Precence or abcencs

    Time frame: 2 years

07

Study locations

1 of 1 sites recruiting
  • Minia University
    Minya, 61111, Egypt
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 25, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05020223
Lead sponsor
Minia University
Responsible party
Mahmoud Ahmed Mahmoud (Lecturer, Minia University) — Principal investigator
First posted
Aug 25, 2021
Start date
Aug 1, 2020
Primary completion
Aug 1, 2023 (estimated)
Completion
Sep 1, 2023 (estimated)
Last update
Aug 25, 2021

Study contacts

Mahmoud A Mahmoud
Contact
Mam.dent@gmail.com
01009578837

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion